1 year return (CAGR)
20.23%
Indaptus Therapeutics Inc Exchange (NASDAQ, USD)
INDP
3.09
-0.46 (-12.96%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-67.28%
5 year return (CAGR)
-56.77%
10 year return (CAGR)
-72.12%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
411.72M
Price/Sales
-
Ent value
404.78M
Price/Book
36.20
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-72.82%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.55 |
| Daily high | 3.55 |
| Daily low | 2.90 |
| Daily Volume | 719K |
| All-time high | 1341706240.00 |
| 1y analyst estimate | 10.00 |
| Beta | 1.18 |
| EPS (TTM) | -0.13 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| INDP | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.56% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 21 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -73.43% | -10.68% |
| Avg time to new high | 112 days | 12 days |
| Max time to new high | 2258 days | 1805 days |
News
